Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov 1;91(5):e136.
doi: 10.1227/neu.0000000000002126. Epub 2022 Sep 2.

In Reply: Safety and Efficacy of the Off-Label Use of Pipeline Embolization Device Based on the 2018 Food and Drug Administration-Approved Indications for Intracranial Aneurysms: A Single-Center Retrospective Cohort Study

Alejandro Enriquez-Marulanda  1 , Anirudh Penumaka, Christopher S Ogilvy, Ajith J Thomas, Justin M Moore
Affiliations
Comment

In Reply: Safety and Efficacy of the Off-Label Use of Pipeline Embolization Device Based on the 2018 Food and Drug Administration-Approved Indications for Intracranial Aneurysms: A Single-Center Retrospective Cohort Study

Alejandro Enriquez-Marulanda et al. Neurosurgery. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Cler SJ, Lauzier DC, Kansagra AP. Letter: Safety and efficacy of the off-label use of pipeline embolization device based on the 2018 Food and Drug Administration-approved indications for intracranial aneurysms: a single-center retrospective cohort study. Neurosurgery. 2022;91(5):E135.
    1. Enriquez-Marulanda A, Penumaka A, Ogilvy CS, Thomas AJ, Moore JM. Safety and efficacy of the off-label use of pipeline embolization device based on the 2018 Food and Drug Administration-approved indications for intracranial aneurysms: a single-center retrospective cohort study. Neurosurgery. 2022;90(6):700-707.
    1. Maragkos GA, Ascanio LC, Salem MM, et al. Predictive factors of incomplete aneurysm occlusion after endovascular treatment with the pipeline embolization device. J Neurosurg. 2019;132(5):1598-1605.
    1. Cler SJ, Lauzier DC, Chatterjee AR, et al. Comparative study of on-label versus off-label treatment of intracranial aneurysms with the pipeline embolization device. J Neurosurg. Published online ahead of print January 28, 2022. DOI: 10.3171/2021.11.JNS212481. - DOI
    1. Enriquez-Marulanda A, Penumaka A, Ogilvy C, et al. Middle meningeal artery embolization versus conventional treatment of chronic subdural hematomas. Neurosurgery. 2022;90(6):700-707.